As TRIPS coun­cil meets, the IP waiv­er for vac­cines is on life sup­port ahead of a De­cem­ber dead­line

The WTO’s TRIPS Coun­cil is meet­ing to­day and to­mor­row to dis­cuss a Covid-19 vac­cine IP waiv­er that re­mains di­vi­sive and un­like­ly to be adopt­ed thanks to Eu­ro­pean op­po­si­tion, but which pro­po­nents still think could un­lock more vac­cine dos­es for low and mid­dle-in­come coun­tries.

Fol­low­ing the meet­ings this week, it’s ex­pect­ed there will be a bet­ter sense if some kind of waiv­er can be agreed to by De­cem­ber, Tahir Amin, an IP lawyer and co-ex­ec­u­tive di­rec­tor of I-Mak, told End­points News.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.